Alternative Data for Amedisys
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,000 | Sign up | Sign up | Sign up |
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | 89,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 107 | Sign up | Sign up | Sign up |
| Facebook Followers | 18,191 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 792 | Sign up | Sign up | Sign up |
| X Followers | 1,228 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 286 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 46 | Sign up | Sign up | Sign up |
| Linkedin Employees | 9,395 | Sign up | Sign up | Sign up |
About Amedisys
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care.
| Price | $100.99 |
| Target Price | Sign up |
| Volume | 1,060,000 |
| Market Cap | $3.32B |
| Year Range | $93.43 - $100.99 |
| Dividend Yield | 0% |
| PE Ratio | 39.3 |
| Analyst Rating | 17% buy |
| Industry | Medical Care Facilities |
In the news
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 622M | 130M | 492M | 68M | 46M | 1.540 |
| Q1 '25 | 595M | 334M | 261M | 61M | 89M | 1.250 |
| Q4 '24 | 598M | 345M | 253M | -20M | 3.2M | 0.960 |
| Q3 '24 | 588M | 338M | 250M | 41M | 26M | 1.000 |
| Q2 '24 | 591M | 461M | 131M | 32M | 70M | 1.320 |
Insider Transactions View All
| Guidroz Allyson filed to sell 8,114 shares at $96. May 9 '25 |
| Guidroz Allyson filed to sell 8,761 shares at $92. March 6 '25 |
| North Michael Paul filed to sell 4,164 shares at $86.4. March 8 '23 |
| Bohnert Denise M. filed to sell 11,850 shares at $115. June 27 '22 |
| Kemmerly David L filed to sell 18,816 shares at $175.2. April 4 '22 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Lisa McClain |
Sep 15, 25 | Sell | $1K - $15K |
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
Read more about Amedisys (AMED) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Amedisys
The Market Cap of Amedisys is $3.32B.
As of today, Amedisys' PE (Price to Earnings) ratio is 39.3.
Currently, the price of one share of Amedisys stock is $100.99.
The AMED stock price chart above provides a comprehensive visual representation of Amedisys' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amedisys shares. Our platform offers an up-to-date AMED stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Amedisys (AMED) does not offer dividends to its shareholders. Investors interested in Amedisys should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Amedisys are Encompass Health, Brookdale Senior Living, DaVita, Tenet Healthcare, and Nutex Health.
